HER-2/neu × aromatase double transgenic mice model: The effects of aromatase overexpression on mammary tumorigenesis

Journal of Steroid Biochemistry and Molecular Biology

Volumn 106, Issue 1-5, 2007, Pages 111-118

  Tekmal, Rajeshwar Rao ^a   Nair, Hareesh B ^a   Perla, Rao P ^a   Kirma, Nameer ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Aromatase; HER 2 neu; Hormonal carcinogenesis; Mammary tumorigenesis; Transgenic mice

Indexed keywords

ANTIESTROGEN; AROMATASE; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA AGONIST; ESTROGEN RECEPTOR ANTAGONIST; ESTROGEN RECEPTOR BETA; RETINOBLASTOMA PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TETRAHYDROCHRYSENE; UNCLASSIFIED DRUG; PROGESTERONE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INCIDENCE; CANCER PREVENTION; CONTROLLED STUDY; ENZYME ANALYSIS; ESTROGEN ACTIVITY; FEMALE; GENE OVEREXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; ANIMAL; BIOLOGICAL MODEL; CELL TRANSFORMATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOPLASMIC RETICULUM; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

ANIMALS; AROMATASE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; ENDOPLASMIC RETICULUM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHOSPHORYLATION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETINOBLASTOMA PROTEIN;

EID: 34548435170     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.05.009     Document Type: Article

References (37)

1. Tekmal R.R., and Santen R.J. Local estrogen production: is aromatase an oncogene?. In: Manni A. (Ed). Contemporary Endocrinology: Endocrinology of Breast Cancer (1999), Humana Press, New Jersey 79-89
2. Santen R.J., Santner S.J., Pauley R.J., Tait L., Kaseta J., Demers L.M., Hamilton C., and Wang J.-P. Estrogen production via the aromatase enzyme in breast cancer carcinoma: which cell type is responsible?. J. Steroid Biochem. Mol. Biol. 61 (1997) 267-271
3. Santner S.J., Pauley J.P., Tait L., Kaseta J., and Santen R.J. Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J. Clin. Endocrinol. Metab. 82 (1997) 200-208
4. Anderson E., Clarke R.B., and Howell A. Estrogen responsiveness and control in normal human breast proliferation. J. Mammary Gland Biol. Neoplasia 3 (1998) 23-35
5. Nicholson R.I., McClelland R.A., Robertson J.F., and Gee J.M. Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer. Endocr. Relat. Cancer 6 (1999) 373-387
6. Edwards D.P. Regulation of signal transduction pathways by estrogen and progesterone. Annu. Rev. Physiol. 67 (2005) 335-376
7. McGuire W.L., Adams D.J., and Edwards E.P. Estrogen-regulated protein in human breast cancer. J. Steroid Biochem. 20 (1984) 73-81
8. O'Malley B.W. Sequentiality and processivity of nuclear receptor coregulators in regulation of target gene expression. Nucl. Recept. Signal. 1 (2003) e010-e015
9. McKenna N.J., and O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 (2002) 465-474
10. Razandi M., Pedram A., Park S.T., and Levin E.R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 278 (2003) 2701-2712
11. Gustafsson J.A. Therapeutic potential of selective estrogen receptor modulators. Curr. Opin. Chem. Biol. 2 (1998) 508-511
12. Schiff R., Massarweh S.A., Shou J., Bharwani L., Arpino G., Rimawi M., and Osborne C.K. Advanced concepts in estrogen receptor biology-estrogen receptor coregulators. Cancer Chemother. Pharmacol. 56 Suppl. 1 (2005) 10-20
13. Font de Mora J., and Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20 (2000) 5041-5047
14. Tekmal R.R., Ramachandra N., Gubba S., Durgam V.R., Mantione J., Toda K., Shizuta Y., and Dillehay D. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res. 56 (1996) 3180-3185
15. Kirma N., Gill K., Mandava U., and Tekmal R.R. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, anti tumor suppressor functions in the mammary glands of transgenic mice. Cancer Res. 61 (2000) 1910-1918
16. Muller W.J., Sinn E., Pattengale P.K., Wallace R., and Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated neu oncogene. Cell 54 (1988) 105-115
17. Subbaramaiah K., Howe L.R., Port E.R., Brogi E., Fishman J., Liu C.H., hla T., Hudis C., and Dannenberg A.J. HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism. Cancer Res. 66 (2006) 5504-5511
18. Hannah D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
19. Keshava N., Mandava U., Kirma N., and Tekmal R.R. Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz[a]anthracene. Cancer Lett. 167 (2001) 125-133
20. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., and Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 231 (1986) 1150-1154
21. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5925-5930
22. Hewitt S.C., Harell J.C., and Korach K.S. Lessons in estrogen biology from knockout and transgenic animals. Ann. Rev. Physiol. 67 (2005) 285-308
23. Koehler K.F., Helguero L.A., Haldosen L.A., Warner M., and Gustafsson J.A. Reflections on the discovery and significance of estrogen receptor beta. Endocr. Rev. 26 (2005) 465-478
24. Tekmal R.R., Liu Y.G., Nair H.B., Jones J., Perla R.P., Lubahn D.B., Korach K.S., and Kirma N.B. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice. J. Steroid Biochem. Mol. Biol. 95 (2005) 9-15
25. Forster C., Makela S., Warri A., Kietz S., Becker D., Hultenby K., Warner M., and Gustafsson J.A. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15578-15583
26. kip1, a cyclin-CDK inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8 (1994) 9-22
27. Pestell R.G., Albanese C., Reutens A.T., Segall J.E., Lee R.J., and Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20 (1999) 501-534
28. Prall O.W.J., Sarcevic P., Musgrove E.A., Watts C.K.W., and Sutherland R.L. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased Cyclin D1 expression and decreased Cyclin-dependent kinase inhibitor association with Cyclin E-CDK2. J. Biol. Chem. 272 (1997) 10882-10894
29. Yu Q., Geng Y., and Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 411 (2001) 1017-1021
30. Yu Q., Sicinska E., Geng Y., Ahnstrom M., Zagozdson A., Kong Y., Gardner H., Kiyokawa H., Harris L.N., Stal O., and Sicinski P. Requirement for CDK4 kinase function in breast cancer. Cancer Cell 9 (2006) 23-32
31. Reddy H.K., Mettus R.V., Rane S.G., Grana X., Litvin J., and Reddy E.P. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. Cancer Res. 65 (2005) 10174-10178
32. MacMohan B., Cole P., and Lin T.M. Age at first birth and breast cancer risk. Bull. World Health Organ. 43 (1970) 209-221
33. Russo J., Moral R., Balogh G.A., Mallo D., and Russo I.H. The protective role of pregnancy in breast cancer. Breast Cancer Res. 7 (2005) 131-142
34. Russo I.H., and Russo J. Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 104 (1996) 938-967
35. Medina D., and Smith G.H. Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J. Natl. Cancer Inst. 91 (1999) 967-969
36. Rajkumar L., Guzman R.C., Yang J., Thordarson G., Talamantes F., and Nandi S. Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 11755-11759
37. Guzman R.C., Yang J., Rajkumar L., Thordarson G., Talamantes F., and Nandi S. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2520-2525